The presentation of the new long-acting growth hormone for the treatment of GH deficiency in pediatric age, developed by Pfizer, which obtained reimbursement in Italy, took place in Rome. The meeting explored clinical and psychological aspects of a rare pathology whose prevalence ranges from 1/4000 to 1/10,000 children.
#Pfizer #launches #innovative #treatment #deficiency #pediatric #age